179 related articles for article (PubMed ID: 9305912)
1. Functional dissection of the pro-apoptotic protein Bik. Heterodimerization with anti-apoptosis proteins is insufficient for induction of cell death.
Elangovan B; Chinnadurai G
J Biol Chem; 1997 Sep; 272(39):24494-8. PubMed ID: 9305912
[TBL] [Abstract][Full Text] [Related]
2. Functional identification of the apoptosis effector BH3 domain in cellular protein BNIP1.
Yasuda M; Chinnadurai G
Oncogene; 2000 May; 19(19):2363-7. PubMed ID: 10822388
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of the pro-apoptotic protein BIK: mapping of phosphorylation sites and effect on apoptosis.
Verma S; Zhao LJ; Chinnadurai G
J Biol Chem; 2001 Feb; 276(7):4671-6. PubMed ID: 11084041
[TBL] [Abstract][Full Text] [Related]
4. Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins.
Boyd JM; Gallo GJ; Elangovan B; Houghton AB; Malstrom S; Avery BJ; Ebb RG; Subramanian T; Chittenden T; Lutz RJ
Oncogene; 1995 Nov; 11(9):1921-8. PubMed ID: 7478623
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus E1B-19K/BCL-2 interacting protein BNIP3 contains a BH3 domain and a mitochondrial targeting sequence.
Yasuda M; Theodorakis P; Subramanian T; Chinnadurai G
J Biol Chem; 1998 May; 273(20):12415-21. PubMed ID: 9575197
[TBL] [Abstract][Full Text] [Related]
6. Bcl-XL protects BimEL-induced Bax conformational change and cytochrome C release independent of interacting with Bax or BimEL.
Yamaguchi H; Wang HG
J Biol Chem; 2002 Nov; 277(44):41604-12. PubMed ID: 12198137
[TBL] [Abstract][Full Text] [Related]
7. The proteasome inhibitor bortezomib sensitizes cells to killing by death receptor ligand TRAIL via BH3-only proteins Bik and Bim.
Nikrad M; Johnson T; Puthalalath H; Coultas L; Adams J; Kraft AS
Mol Cancer Ther; 2005 Mar; 4(3):443-9. PubMed ID: 15767553
[TBL] [Abstract][Full Text] [Related]
8. The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4.
Huang DC; Adams JM; Cory S
EMBO J; 1998 Feb; 17(4):1029-39. PubMed ID: 9463381
[TBL] [Abstract][Full Text] [Related]
9. The pro-apoptotic protein, Bik, exhibits potent antitumor activity that is dependent on its BH3 domain.
Tong Y; Yang Q; Vater C; Venkatesh LK; Custeau D; Chittenden T; Chinnadurai G; Gourdeau H
Mol Cancer Ther; 2001 Dec; 1(2):95-102. PubMed ID: 12467227
[TBL] [Abstract][Full Text] [Related]
10. Bok is a pro-apoptotic Bcl-2 protein with restricted expression in reproductive tissues and heterodimerizes with selective anti-apoptotic Bcl-2 family members.
Hsu SY; Kaipia A; McGee E; Lomeli M; Hsueh AJ
Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12401-6. PubMed ID: 9356461
[TBL] [Abstract][Full Text] [Related]
11. BH3 domain of BAD is required for heterodimerization with BCL-XL and pro-apoptotic activity.
Zha J; Harada H; Osipov K; Jockel J; Waksman G; Korsmeyer SJ
J Biol Chem; 1997 Sep; 272(39):24101-4. PubMed ID: 9305851
[TBL] [Abstract][Full Text] [Related]
12. Induction of apoptosis by human Nbk/Bik, a BH3-containing protein that interacts with E1B 19K.
Han J; Sabbatini P; White E
Mol Cell Biol; 1996 Oct; 16(10):5857-64. PubMed ID: 8816500
[TBL] [Abstract][Full Text] [Related]
13. Minimal BH3 peptides promote cell death by antagonizing anti-apoptotic proteins.
Moreau C; Cartron PF; Hunt A; Meflah K; Green DR; Evan G; Vallette FM; Juin P
J Biol Chem; 2003 May; 278(21):19426-35. PubMed ID: 12642586
[TBL] [Abstract][Full Text] [Related]
14. Survival activity of Bcl-2 homologs Bcl-w and A1 only partially correlates with their ability to bind pro-apoptotic family members.
Holmgreen SP; Huang DC; Adams JM; Cory S
Cell Death Differ; 1999 Jun; 6(6):525-32. PubMed ID: 10381646
[TBL] [Abstract][Full Text] [Related]
15. Evidence for involvement of BH3-only proapoptotic members in adenovirus-induced apoptosis.
Subramanian T; Vijayalingam S; Lomonosova E; Zhao LJ; Chinnadurai G
J Virol; 2007 Oct; 81(19):10486-95. PubMed ID: 17652400
[TBL] [Abstract][Full Text] [Related]
16. Bax can antagonize Bcl-XL during etoposide and cisplatin-induced cell death independently of its heterodimerization with Bcl-XL.
Simonian PL; Grillot DA; Merino R; Nuñez G
J Biol Chem; 1996 Sep; 271(37):22764-72. PubMed ID: 8798452
[TBL] [Abstract][Full Text] [Related]
17. Heterodimerization-independent functions of cell death regulatory proteins Bax and Bcl-2 in yeast and mammalian cells.
Zha H; Reed JC
J Biol Chem; 1997 Dec; 272(50):31482-8. PubMed ID: 9395483
[TBL] [Abstract][Full Text] [Related]
18. Mutagenesis of the BH3 domain of BAX identifies residues critical for dimerization and killing.
Wang K; Gross A; Waksman G; Korsmeyer SJ
Mol Cell Biol; 1998 Oct; 18(10):6083-9. PubMed ID: 9742125
[TBL] [Abstract][Full Text] [Related]
19. Dimerization properties of human BAD. Identification of a BH-3 domain and analysis of its binding to mutant BCL-2 and BCL-XL proteins.
Ottilie S; Diaz JL; Horne W; Chang J; Wang Y; Wilson G; Chang S; Weeks S; Fritz LC; Oltersdorf T
J Biol Chem; 1997 Dec; 272(49):30866-72. PubMed ID: 9388232
[TBL] [Abstract][Full Text] [Related]
20. Reversal of Mutant KRAS-Mediated Apoptosis Resistance by Concurrent Noxa/Bik Induction and Bcl-2/Bcl-xL Antagonism in Colon Cancer Cells.
Okamoto K; Zaanan A; Kawakami H; Huang S; Sinicrope FA
Mol Cancer Res; 2015 Apr; 13(4):659-69. PubMed ID: 25548100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
